We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+6.49%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$21.9B
AUM Growth
+$3.56B
(+19%)
Cap. Flow
-$3.04B
Cap. Flow
% of AUM
-13.9%
Top 10 Holdings %
Top 10 Hldgs %
21.13%
Holding
1,032
New
106
Increased
310
Reduced
130
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$91.3M |
| 2 |
Apple
AAPL
|
+$85.5M |
| 3 |
Amazon
AMZN
|
+$61.3M |
| 4 |
Meta Platforms (Facebook)
META
|
+$56.6M |
| 5 |
UnitedHealth
UNH
|
+$31.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$57.8M |
| 2 |
iShares Russell 2000 Value ETF
IWN
|
+$15M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$14.9M |
| 4 |
iShares MSCI United Kingdom ETF
EWU
|
+$12.7M |
| 5 |
COUP
Coupa Software Incorporated
COUP
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.08% |
| 2 | Financials | 7.86% |
| 3 | Healthcare | 7.35% |
| 4 | Consumer Discretionary | 6.89% |
| 5 | Communication Services | 6.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCUE
51
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
| $64.3M | 0.29% |
661,975
+908
| +0.1% | +$91.9K |
|
52
ExxonMobil
XOM
$651B
| $62.6M | 0.29% |
992,242
+110,044
| +12% | +$6.57M |
|
53
Lam Research
LRCX
$382B
| $61M | 0.28% |
937,620
-20,330
| -2% | -$1.28M |
|
54
Merck
MRK
$324B
| $59.1M | 0.27% |
759,439
+84,336
| +12% | +$6.27M |
|
55
Medtronic
MDT
$107B
| $57.3M | 0.26% |
461,851
+69,263
| +18% | +$8.7M |
|
|
CFXA
56
DELISTED
Colfax Corporation 5.75% Tangible Equity Units
CFXA
| $56.5M | 0.26% |
303,520
| – | – |
|
57
PepsiCo
PEP
$186B
| $56.4M | 0.26% |
380,853
+60,744
| +19% | +$8.85M |
|
58
Pfizer
PFE
$140B
| $54.4M | 0.25% |
1,389,803
+249,928
| +22% | +$9.72M |
|
59
McDonald's
MCD
$188B
| $53.5M | 0.24% |
231,621
+38,320
| +20% | +$8.92M |
|
60
Citigroup
C
$222B
| $53.3M | 0.24% |
752,652
+92,299
| +14% | +$6.83M |
|
61
Bristol-Myers Squibb
BMY
$127B
| $53.2M | 0.24% |
796,371
+114,232
| +17% | +$7.45M |
|
62
AbbVie
ABBV
$458B
| $52.9M | 0.24% |
469,437
+203,536
| +77% | +$22.9M |
|
63
Mondelez International
MDLZ
$77.7B
| $52.5M | 0.24% |
840,400
+302,548
| +56% | +$18.6M |
|
|
NEE.PRQ
64
DELISTED
NextEra Energy, Inc. 6.219% Corporate Units
NEE.PRQ
| $52.2M | 0.24% |
1,055,898
+2,450
| +0.2% | +$122K |
|
65
Paycom
PAYC
$6.78B
| $51.8M | 0.24% |
142,476
+17,795
| +14% | +$6.31M |
|
66
Lowe's Companies
LOW
$116B
| $51.1M | 0.23% |
263,197
+44,006
| +20% | +$8.61M |
|
67
Danaher
DHR
$135B
| $50M | 0.23% |
210,294
+67,626
| +47% | +$15M |
|
68
Boston Scientific
BSX
$65.8B
| $49.2M | 0.22% |
1,150,481
+139,973
| +14% | +$5.89M |
|
69
Oracle
ORCL
$331B
| $49.1M | 0.22% |
631,091
-30,971
| -5% | -$2.42M |
|
70
CALL
iShares Russell 2000 ETF
IWM
$80.9B
| $49.1M | 0.22% |
214,000
-40,000
| -16% | -$8.99M |
|
71
Target
TGT
$62.1B
| $49M | 0.22% |
202,862
+33,200
| +20% | +$7.27M |
|
72
Twilio
TWLO
$29.1B
| $49M | 0.22% |
124,299
+28,090
| +29% | +$9.75M |
|
73
PUT
Snap
SNAP
$7.32B
| $48.7M | 0.22% |
+715,000
| New | +$42.9M |
|
74
Thermo Fisher Scientific
TMO
$211B
| $48.6M | 0.22% |
96,263
-12,858
| -12% | -$6.07M |
|
75
Costco
COST
$415B
| $48.5M | 0.22% |
122,559
+14,397
| +13% | +$5.44M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Calamos Advisors held 1,032 positions worth $21.9B, up 19% from $18.3B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Calamos Advisors withdrew a net $3.04B in Q2 2021, closing 79 positions and reducing 130 holdings. Its most notable exit was iShares Russell 2000 Value ETF, an estimated $15M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Calamos Advisors opened a new position in IQVIA worth $9.51M.
- Calamos Advisors's largest Q2 2021 buy was IQVIA: 39,258 shares worth $9.51M.
- Calamos Advisors added most to Microsoft in Q2 2021, an estimated $91.3M increase.
- Calamos Advisors's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $57.8M.
- Calamos Advisors fully exited iShares Russell 2000 Value ETF in Q2 2021, selling an estimated $15M.
- Calamos Advisors's ten largest holdings make up 21% of its $21.9B portfolio in Q2 2021.
- Calamos Advisors opened 106 new positions and closed 79 in Q2 2021.
- Calamos Advisors's portfolio value rose 19% quarter-over-quarter to $21.9B.
Based on Calamos Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.